Salk is honored to have faculty named in this year’s Highly Cited Researchers list by Clarivate. The 2025 list includes 6,868 researchers from 60 countries who have demonstrated “significant and broad influence in their fields of research.”

www.salk.edu/news-release...

TODAY AT 9 A.M. PT/ 12 P.M.!

Join us for a special *live* podcast episode exploring how the government shutdown impacts our research and the best way for science to move forward.

Be the first to hear exclusive insights and learn how science today shapes the world of tomorrow.

salk.edu/cant-wait

How does learning about a virus help us treat it?

Salk scientists are piecing together the details of HIV replication in search of new treatment avenues for the tens of millions of people living with HIV globally.

A thread🧵

Breakthroughs begin with a question, a quiet moment of curiosity before the cure - before the solution. With government funding in limbo, ideas stall, and time can slip away. But Salk refuses to stand still, because #ScienceCan’tWait

Your support keeps discovery alive.
www.salk.edu/support-us/s...

Salk scientist Satchin Panda took the TEDxBoston stage yesterday with a powerful talk on "Unlocking Longevity." His insights on how circadian rhythms and daily habits impact healthy aging are a must-watch.

tedxboston.com/portfolio/un...

#UnlockingLongevity #TEDxBoston #CircadianRhythms

The Rising Stars Symposium applications are now open. It brings outstanding postdoctoral researchers (in years 3–4 of their training) to Salk to present their work, connect with faculty 1:1, and explore career opportunities,

Application Deadline: December 15, 2025

www.salk.edu/about/our-co...

The National Institutes of Health (NIH) has selected Salk neuroscientist Terrence Sejnowski to receive a 2025 NIH Director's Pioneer Award, supporting his lab's use of advanced computational techniques to analyze and model the neural circuit dynamics of working memory.

www.salk.edu/news-release...

Congratulations to Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi on winning the 2025 Nobel Prize in Physiology or Medicine for uncovering regulatory T cells — the immune system’s peacekeepers that protect our bodies from attacking themselves.

A thread:

At Salk, more than half of our research is powered by federal funding. The government might be shut down, but Salk's science continues.

Why? Because cancer doesn't wait. Alzheimer's disease doesn't wait. So science can't wait either.

Donate today: www.salk.edu/support-us/s...

Applications are now open for the Salk SURF — a fully funded, 10-week program that gives undergraduate students access to world-class facilities, mentorship from leading scientists, and a supportive community of peers.

📅 Deadline: December 7, 2025

Apply today: www.salk.edu/about/our-communi...

The federal government has shut down, leaving many questions unanswered.

At Salk, more than half of our research is supported by federal grants. But in times of uncertainty, science can't wait.

Donate to support science now: www.salk.edu/support-us/s...

Tune into Salk's podcast, Beyond Lab Walls, and meet Tony Hunter, the famed cancer biologist, who just celebrated 50 years at the Institute.

His persistent curiosity has fueled discovery and lifesaving medications, and continues to shape the future of cancer research.

www.salk.edu/blw-podcast/...

Salk scientists have pinpointed the brain area responsible for distinguishing between painful and non-painful touch. When it malfunctions, it can lead to mechanical allodynia.

This new understanding is a crucial step in designing acute and chronic pain therapeutics.

www.salk.edu/news-release...

Could boosting this molecule slow pancreatic cancer?

Salk and UCSD researchers found that increasing HSAT, an anticoagulant, in pancreatic cancer models slowed cancer progression. Its presence in human blood suggests it may also be a powerful biomarker.

Read more: www.salk.edu/news-release...